What were Human Metabolome Technologies,Inc.'s latest financial results?

Human Metabolome Technologies,Inc. (6090.T) reported its latest results in an earnings disclosure filed with the Tokyo Stock Exchange. The full English translation is in the article above.

Where can I read Human Metabolome Technologies,Inc.'s earnings disclosure in English?

Pulse News Wire provides real-time English translations of Human Metabolome Technologies,Inc.'s TDNet filings, including this earnings report.

How quickly are Human Metabolome Technologies,Inc.'s TSE filings translated into English?

Pulse News Wire translates Tokyo Stock Exchange disclosures typically within 5 minutes of filing, covering all 4,436 listed companies including Human Metabolome Technologies,Inc..

| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Human Metabolome Technologies,Inc. FY2026 Earnings Presentation

Source disclosure: February 19, 2026 Human Metabolome Technologies,Inc. [6090.T] TOKYO, Feb 19 (Pulse News Wire) – Human Metabolome Technologies,Inc. (6090.T) released its earnings presentation for FY2026. Revenue was ¥659 million (-3.7% YoY). Operating profit was ¥46 million (-55.2% YoY). Ordinary profit was ¥47 million (-50.3% YoY). Net profit was ¥43 million (-52.9% YoY). For the full year, the company forecasts revenue of ¥1.6 billion. Forecast operating profit is ¥300 million.

Source disclosure: February 19, 2026

Human Metabolome Technologies,Inc. [6090.T]

TOKYO, Feb 19 (Pulse News Wire) – Human Metabolome Technologies,Inc. (6090.T) released its earnings presentation for FY2026.

7% YoY). 2% YoY). 3% YoY).

9% YoY).

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.

AI-translated content. 🟢 Confidence: High See terms • Original filing

💬 Help us improve translation quality

Notice any errors in this article? Let us know with one click.

🎁 Report 3+ errors with your email and get a free month of premium access

Human Metabolome Technologies,Inc. FY2026 Earnings Presentation

Related Disclosures